Search Bar & Filters
Found 7 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the safety and effects of a new medicine called vepugratinib in adults with advanced or metastatic urothelial carcinoma, a type of bladder cancer with a specific FGFR3 genetic alteration. This phase 3 trial compares vepugratinib with a placebo when both are given alongside enfortumab vedotin and pembrolizumab. The study aims to understand if adding vepugratinib improves treatment outcomes and monitors adverse events over an extended period. Participants will receive oral vepugratinib or a matching placebo combined with intravenous enfortumab vedotin and pembrolizumab. The treatments are given in parallel groups, with some participants receiving the experimental drug and others the placebo, all alongside the standard IV therapies. The trial includes a safety lead-in phase and an extended treatment period, with study participation lasting up to approximately six years. During the trial, participants will undergo regular assessments including monitoring of treatment-related side effects, imaging to evaluate tumor response, blood tests to measure drug levels, and quality of life questionnaires. Researchers will track progression-free survival, overall survival, and response rates throughout the study and follow participants closely for safety and health status until study completion.
Actively Recruiting
Healthy Volunteer
This research aims to evaluate how a case-based blended learning program affects nursing students abilities to identify and express psychosocial nursing diagnoses. It focuses on improving students skills in differentiating and correlating psychosocial needs, which are often overlooked in traditional nursing education that tends to emphasize physical needs. The study is designed as a randomized controlled trial led by the University of Yalova to enrich nursing curricula and enhance teaching methods. Participants will undergo an educational program consisting of three sessions that use interactive video-supported materials and case studies. The content covers topics like sexuality and body image, spirituality and hopelessness, social isolation and role performance, and the grieving process, all based on established models. The blended learning approach combines face-to-face teaching with digital learning environments to support various learning styles and provide instant feedback. During the study, nursing students will be assessed before and after the 4-week education module using specific forms to measure their knowledge and skills in psychosocial nursing diagnoses. Researchers will evaluate changes in their understanding and perception of nursing diagnoses. The study aims to strengthen students ability to analyze psychosocial needs holistically and incorporate these insights into care planning.
Actively Recruiting
Healthy Volunteer
Smoking is a major risk factor for heart, lung, and respiratory diseases, especially common among young people and university students in Turkey. Smoking reduces lung function and exercise performance by causing fatigue, breathlessness, and pain. This study aims to compare the effects of two chest-focused exercise techniques, proprioceptive neuromuscular facilitation PNF and chest mobility exercises, on lung function, chest expansion, and functional capacity in university students who are smokers. Participants are divided into three groups one receiving chest PNF exercises, another performing chest mobility exercises combined with diaphragmatic breathing, and a control group with no intervention. The exercise programs last 6 weeks with three 30-minute sessions each week. Chest PNF exercises involve specific hand placements and resistance movements in supine, side-lying, and prone positions, while chest mobility exercises include rotations, stretches, and mobilizations performed in various positions. Throughout the study, participants undergo multiple assessments at the beginning and after about 6 weeks. These include lung function tests using a portable spirometer, breathlessness evaluation, exercise capacity tests, depression and fatigue scales, quality of life questionnaires, chest expansion measurements, physical activity assessments, and endurance testing. Data will be analyzed to see how each intervention affects respiratory health and functional ability in young smokers.
Actively Recruiting
Chronic Obstructive Pulmonary Disease COPD is a serious lung condition that affects breathing and exercise ability, often caused by smoking. COPD leads to respiratory muscle weakness, increased breathlessness, and reduced lung function. Pulmonary rehabilitation, including respiratory muscle training, is a key part of managing COPD. This research aims to compare the early effects of two types of inspiratory muscle trainingbasic and functionalon the health and quality of life of people with COPD. Participants will be randomly assigned to one of three groups basic inspiratory muscle training IMT, functional inspiratory muscle training F-IMT, or a control group. Both IMT groups will use a device to train respiratory muscles at home and with a physiotherapist over eight weeks. The F-IMT group will add specific exercises focused on core and postural muscles during the last four weeks. The control group will perform simple breathing and upper body exercises with similar supervision and home practice. Throughout the study, participants will undergo various assessments including breathing tests, muscle strength measurements, exercise capacity tests, balance and core muscle evaluations, and quality of life questionnaires. These will be done at the start and after eight weeks to monitor changes. The study will also track symptoms like breathlessness, cognitive function, daily activity ability, fatigue, and depression to understand how the trainings affect the course of COPD over time.
Actively Recruiting
Researchers are evaluating the efficacy and safety of adagrasib MRTX849 alone and combined with pembrolizumab in patients with advanced or metastatic non-small cell lung cancer NSCLC who have a KRAS G12C mutation. The study includes both Phase 2 and Phase 3 portions, focusing on patients eligible for first-line treatment with varying levels of PD-L1 expression. The trial compares adagrasib combined with pembrolizumab to pembrolizumab alone in patients with high PD-L1 expression. In Phase 2, patients are divided into three groups based on PD-L1 TPS scores two groups with scores below 1% receive either adagrasib monotherapy or adagrasib plus pembrolizumab, and one group with scores of 1% or higher receives the combination. Phase 3 randomizes patients with PD-L1 TPS of 50% or higher to receive either adagrasib plus pembrolizumab or pembrolizumab alone. Adagrasib is taken orally twice daily, while pembrolizumab is given intravenously every three weeks. Participants undergo regular assessments including brain imaging, tumor measurements, and quality of life questionnaires. Researchers monitor treatment effects, safety, drug levels in blood, and lung cancer symptoms over periods of up to 22 months in Phase 2 and 36 months in Phase 3. The study also evaluates progression-free survival, response duration, and other outcomes to understand the treatments impact.
Actively Recruiting
Researchers are conducting a Phase 23, multisite, randomized, open-label trial to study first-line treatments for non-small cell lung cancer NSCLC. This trial includes two substudies focusing on different NSCLC histological subtypes due to variations in standard chemotherapy choices. The study aims to evaluate the safety, effectiveness, and behavior of the investigational drug pumitamig combined with chemotherapy and compare it to pembrolizumab plus chemotherapy. Participants in each substudy first join a Phase 2 part where they receive one of two doses of pumitamig plus chemotherapy. In the Phase 3 part, they are randomized to receive either pumitamig plus chemotherapy or pembrolizumab plus chemotherapy. Additional participants in China will be enrolled in a Phase 2 arm to further evaluate a selected dose. Independent committees will review safety data and tumor scans throughout the study. Participants will be involved for up to 64 months, undergoing treatments through intravenous infusions. Their health will be monitored regularly to track side effects, tumor response, progression-free survival, overall survival, and quality of life through questionnaires and scans. Safety assessments include monitoring adverse events and treatment tolerance, with follow-up visits extending up to several years to assess long-term outcomes.
Actively Recruiting
Healthy Volunteer
This research aims to evaluate the effects of Baduanjin, a traditional Chinese mind-body exercise, on pain, comfort, and quality of recovery in patients undergoing total knee arthroplasty TKA. The study focuses on understanding whether Baduanjin can improve postoperative outcomes compared to standard care. The trial will take place between July 2025 and July 2026 at Yalova Training and Research Hospitals Orthopedics Clinic with 60 participants randomly assigned into two groups. One group will perform supervised Baduanjin exercises daily starting on the first day after surgery and continuing for three weeks. These exercises consist of eight gentle movements incorporating physical posture, breathing, and mental focus. The control group will receive routine postoperative care and physical therapy without Baduanjin. Data will be collected at four time points before surgery, on the first postoperative day, and at weeks 4 and 8 post-surgery. Participants will undergo assessments using the Visual Analog Scale VAS for pain, the General Comfort Questionnaire, and the Quality of Recovery-40 QoR-40 questionnaire at each time point. The study will monitor pain levels, comfort, and recovery quality throughout the follow-up period. This trial aims to contribute evidence about complementary mind-body methods that may support recovery after knee replacement surgery.